Literature DB >> 15262733

Lack of familial aggregation of Parkinson disease and Alzheimer disease.

Gilberto Levy1, Elan D Louis, Helen Mejia-Santana, Lucien Côté, Howard Andrews, Juliette Harris, Cheryl Waters, Blair Ford, Steven Frucht, Stanley Fahn, Ruth Ottman, Karen Marder.   

Abstract

OBJECTIVE: To investigate the risk of Alzheimer disease (AD) in first-degree relatives of patients with Parkinson disease (PD) compared with first-degree relatives of controls.
DESIGN: Case-control study, family history method, and reconstructed cohort approach.
METHODS: Probands with PD without dementia and control probands, matched by age strata, sex, and ethnicity, were examined in person and enrolled without knowledge of family history of PD and other neurological disorders. Disease status in first-degree relatives of probands with PD and control probands was ascertained through a structured family history interview administered to the proband and a second informant (self-report or another informant). Cox proportional hazards models with double-censoring techniques for missing information on age of onset of AD were used to analyze the risk of AD in first-degree relatives of patients with PD compared with first-degree relatives of controls.
RESULTS: Four hundred eighty-seven probands with PD and 409 control probands provided family history information on 4819 first-degree relatives older than 30 years (2534 relatives of probands with PD and 2285 relatives of control probands). One hundred thirteen first-degree relatives (2.3%; 61 relatives [2.4%] of patients with PD and 52 relatives [2.3%] of controls) were diagnosed with AD. The risk of AD was not increased in relatives of patients with PD compared with relatives of controls (hazard ratio, 1.1; 95% confidence interval, 0.7-1.6; P =.65). Similarly, no significantly increased risk of AD was observed when comparing relatives of patients with early-onset (< or =50 years) and late-onset (>50 years) PD with relatives of controls.
CONCLUSION: The lack of familial aggregation of PD and AD does not support the hypothesis of major shared genetic contributions to the etiology of the 2 most common neurodegenerative disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15262733     DOI: 10.1001/archneur.61.7.1033

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

1.  Familial associations of Alzheimer disease and essential tremor with Parkinson disease.

Authors:  S Costello; Y Bordelon; J Bronstein; B Ritz
Journal:  Eur J Neurol       Date:  2010-03-17       Impact factor: 6.089

2.  Clinical characteristics in early Parkinson's disease in a central California population-based study.

Authors:  Gail A Kang; Jeff M Bronstein; Donna L Masterman; Matthew Redelings; Jarrod A Crum; Beate Ritz
Journal:  Mov Disord       Date:  2005-09       Impact factor: 10.338

3.  Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study.

Authors:  Michael Y Shino; Valerie McGuire; Stephen K Van Den Eeden; Caroline M Tanner; Rita Popat; Amethyst Leimpeter; Allan L Bernstein; Lorene M Nelson
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

4.  Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

Authors:  Karen S Marder; Ming X Tang; Helen Mejia-Santana; Llency Rosado; Elan D Louis; Cynthia L Comella; Amy Colcher; Andrew D Siderowf; Danna Jennings; Martha A Nance; Susan Bressman; William K Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl Waters; Stanley Fahn; Barbara M Ross; Lucien J Cote; Steven Frucht; Blair Ford; Roy N Alcalay; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Brad Hiner; Gregory D Neils; Miguel Verbitsky; Sergey Kisselev; Elise Caccappolo; Ruth Ottman; Lorraine N Clark
Journal:  Arch Neurol       Date:  2010-06

5.  Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.

Authors:  Yuanjia Wang; Lorraine N Clark; Elan D Louis; Helen Mejia-Santana; Juliette Harris; Lucien J Cote; Cheryl Waters; Howard Andrews; Blair Ford; Steven Frucht; Stanley Fahn; Ruth Ottman; Daniel Rabinowitz; Karen Marder
Journal:  Arch Neurol       Date:  2008-04

6.  Evidence for modest familial co-aggregation between dementia and parkinsonism.

Authors:  Adina L Feldman; Karin Wirdefeldt; Anna L V Johansson; Margaret Gatz; Nancy L Pedersen
Journal:  Eur J Epidemiol       Date:  2013-11-19       Impact factor: 8.082

7.  An exploratory study on CLU, CR1 and PICALM and Parkinson disease.

Authors:  Jianjun Gao; Xuemei Huang; Yikyung Park; Albert Hollenbeck; Honglei Chen
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

8.  Integrative analysis of common neurodegenerative diseases using gene association, interaction networks and mRNA expression data.

Authors:  Yu Liu; Mehmet Koyutürk; Sean Maxwell; Zhongming Zhao; Mark R Chance
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2012-03-19

9.  Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history.

Authors:  Ami R Rosen; N Kyle Steenland; John Hanfelt; Stewart A Factor; James J Lah; Allan I Levey
Journal:  Neurogenetics       Date:  2007-09-06       Impact factor: 2.660

10.  Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.

Authors:  Valentina Moskvina; Denise Harold; GianCarlo Russo; Alexey Vedernikov; Manu Sharma; Mohamed Saad; Peter Holmans; Jose M Bras; Francesco Bettella; Margaux F Keller; Nayia Nicolaou; Javier Simón-Sánchez; J Raphael Gibbs; Claudia Schulte; Alexandra Durr; Rita Guerreiro; Dena Hernandez; Alexis Brice; Hreinn Stefánsson; Kari Majamaa; Thomas Gasser; Peter Heutink; Nick Wood; Maria Martinez; Andrew B Singleton; Michael A Nalls; John Hardy; Michael J Owen; Michael C O'Donovan; Julie Williams; Huw R Morris; Nigel M Williams
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.